Abbott Laboratories (NYSE:ABT)
$ 114.76 0.45 (0.39%) Market Cap: 198.27 Bil Enterprise Value: 205.55 Bil PE Ratio: 34.74 PB Ratio: 4.98 GF Score: 94/100

Abbott Laboratories at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 06:05PM GMT
Release Date Price: $78.62 (+0.49%)
Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

All right. Thanks everyone for joining us here. It is my pleasure to have Abbott Laboratories here for this session. Again, I'm Kristen Stewart, the medical supplies and device analyst. And I have Brian Yoor, the CFO.

I have one audience question for you guys just to kind of key up the conversation. I wanted to get your thoughts on how you view Abbott's sustainable organic growth rate for the next 3 years. So you've got choices ranging between less than 4% up to greater than 10%. I'll do the countdown, and you guys can record your responses starting now. So count down.

(Voting)

Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

All right. Brian, are you nervous?

Brian B. Yoor
Abbott Laboratories - Executive VP of Finance & CFO

No. It's my favorite question.

Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

All

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot